The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 25532755 |
46 |
Design and synthesis of new tricyclic indoles as potent modulators of the S1P1 receptor. |
Arena Pharmaceuticals |
| 25516794 |
71 |
(7-Benzyloxy-2,3-dihydro-1H-pyrrolo[1,2-a]indol-1-yl)acetic Acids as S1P1 Functional Antagonists. |
Arena Pharmaceuticals |
| 25516790 |
37 |
Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor. |
Arena Pharmaceuticals |
| 24266709 |
1 |
Novel S1P1 receptor agonists--part 1: From pyrazoles to thiophenes. |
Actelion Pharmaceuticals |
| 22633692 |
51 |
Fused tricyclic indoles as S1P1 agonists with robust efficacy in animal models of autoimmune disease. |
Arena Pharmaceuticals |
| 22405291 |
11 |
Synthesis and evaluation of CS-2100, a potent, orally active and S1P(3)- sparing S1P(1) agonist. |
Daiichi Sankyo |
| 24900318 |
8 |
Discovery of CS-0777: A Potent, Selective, and Orally Active S1P1 Agonist. |
TBA |
| 21852130 |
69 |
Discovery and characterization of potent and selective 4-oxo-4-(5-(5-phenyl-1,2,4-oxadiazol-3-yl)indolin-1-yl)butanoic acids as S1P¿? agonists. |
Arena Pharmaceuticals |
| 29120624 |
58 |
Discovery of a 1-Methyl-3,4-dihydronaphthalene-Based Sphingosine-1-Phosphate (S1P) Receptor Agonist Ceralifimod (ONO-4641). A S1P |
Ono Pharmaceutical |
Search and Browse
